Last reviewed · How we verify
Intramuscular HBV I course
At a glance
| Generic name | Intramuscular HBV I course |
|---|---|
| Sponsor | The HIV Netherlands Australia Thailand Research Collaboration |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Hepatitis B Vaccination (HBV) in HIV Infected Children (PHASE2)
- Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: